China Animal Vaccine Industry Report, 2009-2010

China’s animal vaccine market has grown up steadily despite all the twists and turns in the livestock and poultry breeding market over the past four years. In 2009, the market scale reached around RMB6.2 billion, up 14.8% year-on-year, and will keep expanding with the development of the livestock and poultry breeding market.

Restricted by people’s living habits and economic conditions, animal vaccine R&D and production in China mainly focuses on economic animal vaccines. In the meantime, the development of traditional national compulsory vaccines such as foot and mouth disease vaccine, bird flu vaccine, blue ear disease vaccine, hog cholera vaccine in China are relatively mature as a result of national animal vaccine procurement policies. In 2009, the compulsory vaccines accounted for over 86% shares in the entire animal vaccine market, which was basically shared by domestic companies. China Animal Husbandry Industry Co., Ltd. (CAHIC), Yebio Bioengineering Co., Ltd. (Yebio QD), Inner Mongolia Jinyu Group Co., Ltd. (Jinyu Group), Harbin Pharmaceutical Group Bio-vaccine Co., Ltd. (formerly “The First Bio-product Manufactory of Heilongjiang Province”) and Xinjiang Tecon Animal Husbandry Bio-technology Co., Ltd. (Tecon) accounted for 66.7% shares. However, commercial animal vaccines, pet vaccines in particular, had a higher dependence on import. Imported pet vaccines approximately accounted for 70% of total domestic market sales value, and 30% of total domestic market sales volume.

Besides the operating environment, development status, market scale, supply & demand, competition, import & export and development prospect of China’s animal vaccine industry, the report also made an in-depth analysis of the development, market scale, and development trend of global animal vaccine industry, as well as the operation, development prospect and advantages of China’s key animal vaccine manufacturers.


Report Highlights

[Studien Infos ausblenden]

1. Animal Vaccine Overview
1.1 Definition & Classification of Animal Vaccines
1.2 Definition & Classification of Animal Biological Products

2. Animal Vaccine Industry Operating Environment
2.1 Macro Environment
2.2 Policy Environment
2.3 Social Environment

3. Global Animal Vaccine Industry
3.1 Overview
3.2 Market Scale
3.3 Key Countries and Regions
3.3.1 USA
3.3.2 Europe
3.4 Development Prospect

4. China’s Animal Vaccine Industry
4.1 Overview
4.2 Market Scale
4.3 Supply & Demand
4.4 Competition
4.5 Import & Export
4.5.1 Export
4.5.2 Import
4.6 Development Prospect

5. Animal Vaccine Market Segments in China
5.1 Swine Vaccines
5.2 Poultry Vaccines
5.3 Cattle & Sheep Vaccines
5.4 Pet Vaccines

6. Key Manufacturers
6.1 CAHIC
6.1.1 Company Profile
6.1.2 Operation
6.1.3 Animal Vaccine Business
6.1.4 Animal Vaccine Business Development Prospect & Advantages
6.2 Jinyu Group
6.2.1 Company Profile
6.2.2 Operation
6.2.3 Animal Vaccine Business
6.2.4 Animal Vaccine Business Development Prospect & Advantages
6.3 Tecon
6.3.1 Company Profile
6.3.2 Operation
6.3.3 Animal Vaccine Business
6.3.4 Animal Vaccine Business Development Prospect
6.4 Ningbo Tech-Bank
6.4.1 Company Profile
6.4.2 Operation
6.4.3 Chengdu Tech-Bank (formerly Chengdu Jinghua)
6.5 Shenghua Biok
6.5.1 Company Profile
6.5.2 Operation
6.5.3 Yebio QD
6.6 Huasun Group
6.6.1 Company Profile
6.6.2 Operation
6.6.3 Sichuan Huasun
6.7Harbin Pharmaceutical Group
6.7.1 Company Profile
6.7.2 Animal Vaccine Business Status Quo & Prospect
6.8 Foreign Manufacturers in China
6.8.1 Merial
6.8.2 Boehringer-Ingelheim
6.8.3 Bayer
6.8.4 Novartis
[Inhaltsverzeichnis ausblenden]

Animal Vaccine Types and Characteristics
China’s GDP Growth Margin Changes, 2007-2010Q1
China’s Meat, Poultry & Egg and Milk Output, 2007-2009
World’s Animal Vaccine Output Value Distribution, 2008
World’s Animal Vaccine Market Structure by Animal Species, 2009
World’s Animal Vaccine Market Scale, 2004, 2008 & 2009
U.S. Animal Vaccine Product Structure by Animal Species, 2009
U.S. Main Animal Vaccines Output, 2008
U.S. Various Animal Vaccines Y-o-Y Changes, 2008
U.S. Main Animal Vaccine Product Types, 2008
European Animal Vaccine Product Structure, 2009
China’s Animal Vaccine Market Share by Category, 2009
China’s Animal Vaccine Industry Market Scale & Growth, 2006-2009
China’s Key Animal Vaccine Manufacturers
Production of China’s Key Animal Vaccine Manufacturers
China’s Animal Vaccine Consumption Structure by Animal Species, 2009
China’s Animal Vaccination Program, 2010
Market Shares of China’s Main Animal Vaccine Manufacturers by Sales, 2009
Quantity of Manufacturers of Key Leading Companies in Government Animal Vaccine Procurement, 2009
China’s Animal Vaccine Export Volume, Value and Average Unit Price, 2007-2009
China’s Animal Vaccine Oversea Market Distribution, 2009
China’s Animal Vaccine Import Volume, Value and Average Unit Price, 2007-2009
Origins of China’s Imported Animal Vaccines, 2009
China’s Animal Vaccine Industry Development Driving Forces
China’s Animal Vaccine Market Scale, 2010
China’s Pig Inventory and Slaughter Quantity, 2000-2009
China’s Pig Vaccine Market Scale, 2008-2009
Performance Comparison of China’s Various Hog Cholera Vaccines
China’s Poultry Vaccine Market Scale, 2008-2009
Ratio of China’s Poultry Vaccine by Category, 2009
Cattle & Sheep Vaccine Market Scale, 2008-2009
Foot and Mouth Disease in China, 2009
China’s Pet Vaccine Market Scale, 2008-2010
China’s Pet Vaccine Suppliers
CAHIC Operating Income and Net Income, 2007-2010Q1
CAHIC Operating Profit Margin Change, 2007-2009
CAHIC Operating Income & Structure, 2007-2009
CAHIC Operating Income by Region, 2009
CAHIC Animal Vaccine Output Capacity Distribution
CAHIC Animal Vaccine Sales Ratio by Category, 2007-2009
CAHIC Compulsory Vaccine and Market- oriented Vaccine Ratios, 2009
CAHIC Compulsory Vaccine Ratio by Category, 2009
CAHIC Animal Vaccine Gross Profit, 2007-2009
Jinyu Group Operating Income and Net Income, 2007-2010Q1
Jinyu Group Operating Income & Structure, 2007-2009
Jinyu Group Operating Profit Margin Change, 2007-2009
Jinyu Group Operating Income by Region, 2009
Jinyu Group Animal Vaccine Output Capacity Distribution
Jinyu Group Operating Income and Gross Profit Margin Change, 2007-2009
Tecon Operating Income and Net Income, 2007-2010Q1
Tecon Operating Income and Structure, 2007-2009
Tecon Operating Profit Margin Change, 2007-2009
Ratio of Tecon R&D Input to Operating Income, 2007-2009
Tecon Operating Income by Region, 2009
Tecon Animal Vaccine Income and Gross Profit Margin Changes, 2007-2009
Ningbo Tech-Bank Operating Income and Net Income, 2008-2010Q1
Ningbo Tech-Bank Operating Income and Structure, 2008-2009
Ningbo Tech-Bank Main Product Gross Profit Margin Changes, 2008-2009
Chengdu Tech-Bank Animal Vaccine Income Structure, 2009
Shenghua Biok Operating Income and Net Income, 2007-2009
Shenghua Biok Operating Income and Structure, 2007-2009
Shenghua Biok Operating Profit Margin Change, 2007-2009
Yebio QD Operating Income and Net Income, 2008-2009
Huasun Group Operating Income and Net Income, 2007-2009
Huasun Group Operating Income and Structure, 2008-2009
Huasun Group Gross Profit Margin Change, 2007-2009
[Tabellenverzeichnis ausblenden]